Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: Endocr Pract. 2020 Dec 14;27(3):228–235. doi: 10.1016/j.eprac.2020.12.004

Table 1.

Patient Characteristics According to Charlson Comorbidity Index Score

Total N=3280 CCS 0
N=1910 (58%)
CCS 1
N=829 (25%)
CCS 2
N=312 (9%)
CCS 3
N=229 (7%)
Age At Diagnosis
 66-69 768 (40%) 272 (33%) 101 (32%) 72 (31%)
 70-74 600 (31%) 279 (34%) 114 (37%) 71 (31%)
 76-80 352 (18%) 170 (21%) 60 (19%) 48 (21%)
 80+ 190 (9.9%) 108 (13%) 37 (12%) 38 (17%)
Sex
 Female 1556 (81%) 649 (78%) 237 (76%) 166 (72%)
 Male 354 (19%) 180 (22%) 75 (24%) 63 (28%)
Ethnicity
 Caucasian 1682 (88%) 704 (85%) 254 (81%) 158 (69%)
 Other 158 (8.3%) 75 (9.0%) 31 (9.9%) 36 (16%)
 African American 70 (3.7%) 50 (6.0%) 27 (8.7%) 35 (15%)
Marital Status
 Married 1137 (60%) 487 (59%) 161 (52%) 116 (51%)
 Unmarried 773 (40%) 342 (41%) 151 (48%) 113 (49%)
Urban-rural Residence
 Metropolitan 1626 (85%) 691 (83%) 270 (87%) 193 (84%)
 Non-metropolitan 284 (15%) 138 (17%) 42 (13%) 36 (16%)
Geographic Region
 Midwest 216 (11%) 101 (12%) 30 (9.6%) 29 (13%)
 Northeast 425 (22%) 196 (24%) 71 (23%) 53 (23%)
 South 457 (24%) 217 (26%) 96 (31%) 63 (28%)
 West 812 (43%) 315 (38%) 115 (37%) 84 (37%)
Census Tract Median Income
 4th Quartile 538 (28%) 195 (24%) 62 (20%) 46 (20%)
 3rd Quartile 487 (25%) 215 (26%) 78 (25%) 56 (24%)
 2nd Quartile 463 (24%) 209 (25%) 82 (26%) 57 (25%)
 1st Quartile/Unknown 422 (22%) 210 (25%) 90 (29%) 70 (31%)
Diagnosis Year
 1992-2003 358 (19%) 126 (15%) 49 (16%) 31 (14%)
 2004-2013 1552 (81%) 703 (85%) 263 (84%) 198 (86%)
Surgery
 Total/Subtotal 1116 (58%) 464 (56%) 190 (61%) 135 (59%)
 Hemi 794 (42%) 365 (44%) 122 (39%) 94 (41%)
Tumor Size
 T1a 1362 (71%) 586 (71%) 226 (72%) 167 (73%)
 T1b 548 (29%) 243 (29%) 86 (28%) 62 (27%)
Status as Last Follow Up
 Alive 1740 (91%) 706 (85%) 257 (82%) 167 (73%)
 Died 170 (8.9%) 123 (15%) 55 (18%) 62 (27%)